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Age is the dominant risk factor for cardiovascular diseases. Understanding the coupling
between the left ventricle (LV) and arterial system, termed arterial–ventricular coupling
(EA/ELV), provides important mechanistic insights into the complex cardiovascular system
and its changes with aging in the absence and presence of disease. EA/ELV can be indexed
by the ratio of effective arterial elastance (EA; a measure of the net arterial load exerted
on the LV) to left ventricular end-systolic elastance (ELV; a load-independent measure of
left ventricular chamber performance). Age-associated alterations in arterial structure and
function, including diameter,wall thickness,wall stiffness, and endothelial dysfunction, con-
tribute to a gradual increase in resting EA with age. Remarkably there is a corresponding
increase in resting ELV with age, due to alterations to LV remodeling (loss in myocyte num-
ber, increased collagen) and function.These age-adaptations at rest likely occur, at least, in
response to the age-associated increase in EA and ensure that EA/ELV is closely maintained
within a narrow range, allowing for optimal energetic efﬁciency at the expense of mechan-
ical efﬁcacy.This optimal coupling at rest is also maintained when aging is accompanied by
the presence of hypertension, and obesity, despite further increases in EA and ELV in these
conditions. In contrast, in heart failure patients with either reduced or preserved ejection
fraction, EA/ELV at rest is impaired. During dynamic exercise, EA/ELV decreases, due to an
acute mismatch between the arterial and ventricular systems as ELV increases dispropor-
tionate compared to EA (≈200 vs. 40%), to ensure that sufﬁcient cardiac performance is
achieved tomeet the increased energetic requirements of the body. However, with advanc-
ing age the reduction in EA/ELV during acute maximal exercise is blunted, due to a blunted
increase ELV.This impaired EA/ELV is further ampliﬁed in the presence of disease, and may
explain, in part, the reduced cardiovascular functional capacity with age and disease.Thus,
although increased stiffness of the arteries itself has important physiological and clinical
relevance, such changes also have major implications on the heart, and vice versa, and the
manner in theway they interact has important ramiﬁcations on cardiovascular function both
at rest and during exercise. Examination of the alterations in arterial–ventricular coupling
with aging and disease can yield mechanistic insights into the pathophysiology of these
conditions and increase the effectiveness of current therapeutic interventions.
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INTRODUCTION
The population in the Western world is aging; by 2030, there
will be 71 million individuals in the United States over 65 years
of age, representing ≈20% of the U.S. population. Aging signiﬁ-
cantly increases cardiovascular morbidity even in the absence of
other risk factors (e.g., hypertension, obesity, diabetes, hyperc-
holesterolemia). Thus, the risk of death from heart disease is
≈60-fold greater in individuals in the eighth decade compared
to individuals in the 4th decade of life. Not only does clinically
overt cardiovascular disease increase dramatically with aging, but
so do subclinical or occult diseases, such as silent coronary ath-
erosclerosis. Therefore, the aging of the U.S. population is one of
the major public health challenges that we face in the twenty-ﬁrst
century.
The cardiovascular system is modulated to provide sufﬁcient
pressure and ﬂow to the tissues at rest and during exercise.
Understanding the performance (pressure and ﬂow output) of
the left ventricle (LV) requires not only examining the proper-
ties of the LV itself (power and stroke capacity of the heart),
but also investigating the modulating effects of the arterial sys-
tem on left ventricular performance. These modulating effects of
the vasculature include the capacitance and inertial properties
of the aorta, along with the resistance capacity of the micro-
circulation. The interaction of the LV with the arterial system,
termed arterial–ventricular coupling (EA/ELV), is a central deter-
minant of cardiovascular performance and cardiac energetics.
EA/ELV can be indexed by the ratio of effective arterial elastance
(EA) to left ventricular end-systolic elastance (ELV) and is best
displayed in the pressure–volume plane (Figure 1). This review
will describe the concept of arterial ventricular coupling and
how aging, in the absence and presence of cardiovascular dis-
ease, affects the coupling both at rest and during exercise, and
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FIGURE 1 |Ventricular pressure–volume diagram from which effective
arterial elastance (EA) and left ventricular (LV) end-systolic elastance
(ELV) are derived. EA represents the negative slope of the line joining the
end-diastolic volume (EDV) and the end-systolic pressure (ESP) points. ELV
represents the slope of the ESP–volume relationship passing through the
volume intercept (V 0). The shaded area represents the cardiac stroke work,
and the hatched area represents the potential energy. LV ESP is the LV
pressure at the end of systole. EDV is the LV volume at the end of diastole.
End-systolic volume (ESV) is the LV volume at the end of systole. Stroke
volume (SV) is the volume of blood ejected by the LV with each beat and is
obtained from subtracting ESV from EDV. From Chantler et al. (2008a) with
permission.
its physiological consequences. Further, we will discuss potential
therapeutic interventions to restore the coupling between the heart
and arteries.
ARTERIAL–VENTRICULAR COUPLING
The gold standard to assess the arterial afterload that opposes
left ventricular ejection independent of left ventricular function is
through aortic input impedance derived from the Fourier analysis
of aortic pressure and ﬂow (Murgo et al., 1980). However, aortic
input impedance is described in the frequency domain, whereas
measures of left ventricular contraction are best described in the
time domain; consequently making direct comparisons between
arterial and left ventricular function difﬁcult. The pioneeringwork
from Sunagawa et al. (1983) conceived a measure of arterial load
(EA) that could be directly compared to a measure of left ven-
tricular contraction (ELV) in the same units (elastance; change in
pressure for a given change in volume).Rather than speciﬁc arterial
properties, EA simpliﬁes the arterial load into an integrative index
that incorporates the principal elements of arterial load, including
peripheral vascular resistance (which is determined, in large part,
by the small arteries), total arterial compliance (which is deter-
mined, in large part, by the central elastic arteries), characteristic
impedance, and systolic and diastolic time intervals (Sunagawa
et al., 1983). Indeed EA is directly related to heart rate and periph-
eral resistance, and is inversely related to compliance (Chemla
et al., 2003). EA can, therefore, be considered a measure of the
net arterial load that is imposed on the LV. Further, EA measured
invasively as end-systolic pressure/stroke volume closely approx-
imates the arterial load obtained from aortic input impedance
and arterial compliance data based on a three-element Wind-
kessel model (Kelly et al., 1992b). Invasively EA is determined
from pressure–volume loops as the negative slope of the line
joining the end-diastolic volume and end-systolic pressure points
(Figure 1).
The contractile function of the LV can also be expressed from
the slope of the end-systolic pressure–volume relationship (ELV;
Figure 1),which can be obtained from a series of pressure–volume
loops recordedwhile the preload of the heart is altered. ELV reﬂects
a relatively (within normal physiological limits) load-independent
measure of left ventricular contraction (chamber stiffness at end
systole). An increase in contractility is depicted by an increase in
the slope and a shift in the end-systolic pressure–volume relation-
ship to the left,which allows the ventricle to generatemorepressure
for a given left ventricular volume. However, in addition to the
inotropic state, ELV is also inﬂuenced by the geometric (structural
remodeling) and biochemical properties (i.e., stiffness or compli-
ance of myocytes, composition of muscle, ﬁbrosis, collagen, etc.,
in the LV wall) that underlie end-systolic stiffness (Borlaug and
Kass, 2008). Whereby a “stiffer” LV due to remodeling leads to
a higher ELV. Thus, caution should be exercised in interpreting
the signiﬁcance of an elevated ELV, particularly when other mea-
sures of left ventricular systolic function are normal. ELV should,
therefore, be considered an integrated measure of left ventricu-
lar chamber performance that can be related to an integrated
measure of arterial load (i.e., EA). Importantly, EA shares com-
mon units with ELV, and their ratio EA/ELV is a measure of the
interaction between the heart and the arterial system and pro-
vides information about how blood pressure and ﬂow change
due to different loading conditions. See Chantler et al. (2008a)
for a more detailed review of the methods to measure EA and
ELV.
At rest, in healthy individuals the properties of the heart and
arteries are closely matched so that near maximal cardiac work,
power, and chamber efﬁciency are achieved (Little and Cheng,
1991; De Tombe et al., 1993). Values obtained in isolated canine
hearts show the efﬁciency and stroke work of the heart to be opti-
mal over an EA/ELV ratio ranging 0.3–1.3 (Figure 2). Whereas,
in healthy humans the optimal range of EA/ELV to cardiac efﬁ-
ciency and stroke work are generally ranging from 0.7 to 1.0
(Asanoi et al., 1992; Najjar et al., 2004, Redﬁeld et al., 2005).
During exercise, an acute mismatch between the arterial and
ventricular systems occurs due to a disproportionate increase in
ELV vs. EA (Najjar et al., 2004). As a result EA/ELV decreases to
ensure that sufﬁcient cardiac performance is achieved to meet the
increased energetic requirements of the body. In the next section,
we will review the alterations in EA/ELV at rest and during exer-
cise due to aging and illustrate how the age–disease interaction
accentuates the changes in EA/ELV. We will also discuss thera-
peutic interventions aimed to restore the relationship between
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FIGURE 2 | Average normalized SW and SW/MVO2 (efficiency; EFF) as
a function of arterial–ventricular coupling ratio. Both parameters reach
optimal values between EA/Ees (Ees =ELV) ratios spanning 0.3–1.3. From De
Tombe et al. (1993) with permission.
EA and ELV, including the physiological meaning behind the
adaptations.
HEALTHY AGING AND ARTERIAL VENTRICULAR COUPLING
AT REST
Numerous studies have documented a gradual increase in EA with
advancing age (Cohen-Solal et al., 1996; Chen et al., 1998, Red-
ﬁeld et al., 2005). Two small clinical cohort studies calculated EA
from invasive methods of ﬂow and pressure and reported a sig-
niﬁcant rise in EA (44–73%, p< 001) from ≈20 to 70 years of
age (Cohen-Solal et al., 1996; Chen et al., 1998). Although the
strength of these data lies in the invasive assessment of EA, the
small sample size (Cohen-Solal et al., 1996; Chen et al., 1998),
and the inclusion of patients with coronary artery disease, and
individuals on chronic medications (Chen et al., 1998), provides
limited insight into the inﬂuence of healthy aging on EA. Non-
invasive studies of EA have also reported an increase in EA with
age. In a larger epidemiological study consisting of 623 individu-
als from Olmsted County, Minnesota study, Redﬁeld et al. (2005)
observed an age-associated increase in EAI (EA normalized for
body surface area) in both men (r= 0.18, p< 0.01) and women
(r= 0.13, p= 0.02). Inclusion of individuals with existing cardio-
vascular disease further increased the age-associated change in EAI
in bothmen (r = 0.28,p< 0.001) andwomen (r = 0.28,p< 0.001;
Figure 3A).
The speciﬁc mechanisms for the increased EA with age reﬂect
the age-associated changes in the arterial properties of individuals.
EA is a lumped parameter incorporating mean resistance and pul-
satile properties of the arterial load, and is therefore inﬂuenced
by changes in arterial compliance, wave reﬂection, and char-
acteristic impedance (Kelly et al., 1992a). During the past two
decades, we have characterized the effects of aging on multiple
aspects of arterial structure and function in a single study pop-
ulation in the Baltimore Longitudinal Study on Aging (BLSA)
who are rigorously screened to exclude both clinical and occult
cardiovascular disease. Although at rest, peripheral resistance is
FIGURE 3 |The association between age and EA indexed to body
surface area (EAI) (A) and ELV (Ees =ELV) (B) in men (solid line) and
women (dashed line) at rest. Pearson correlation coefﬁcients and
probability values for each association are shown.With advancing age,
both EAI and Ees increase. However, the increase in Ees with age is
signiﬁcantly greater in women than men. Furthermore, EAI and Ees are
higher in women vs. men at all ages. Modiﬁed from Redﬁeld et al.
(2005) with permission.
the dominant factor affecting EA (Chemla et al., 2003) the age-
associated actions of peripheral resistance are heterogeneous to
the extent that only an age-associated increase in resting periph-
eral resistance is noted in healthy women but not men (Fleg et al.,
1995). Indeed, the increase in EA with age noted by Redﬁeld et al.
(2005) is not attributed to an increase in peripheral resistance
as no relationship between age and peripheral resistance existed.
EA is also altered by arterial stiffening and blood pressure pul-
satility increases with age (Franklin et al., 1997) thus raising the
end-systolic pressure required to eject blood thereby increasing
EA. Findings from the BLSA indicate that healthy aging is asso-
ciated with an increase in aortic root diameter, an increase in
carotid wall intimal media thickness, and an overall stiffening
of the large elastic arteries (Najjar et al., 2005). Redﬁeld et al.
(2005) proposed the increase in EA with age is attributable to an
increase in arterial stiffness, manifested by an increase in pulse
pressure (a surrogate measure of arterial stiffening). Thus, the
age-associated increase in EA is largely attributed to an increase
arterial stiffness.
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The heart seems to respond to an increase in EA with a cor-
responding increase in ELV with age (Cohen-Solal et al., 1996;
Chen et al., 1998, Redﬁeld et al., 2005). Cohen-Solal et al. (1996)
noted a 28% higher ELV in men ≈60 vs. 30 years of age. In
the Olmsted County, Minnesota study, Redﬁeld et al. (2005)
noted a 10% (r = 0.16, p< 0.001) and 15% (r = 23, p< 0.0001)
increase in ELV in men and women without cardiovascular dis-
ease, respectively (Figure 3B). These results would suggest that
ELV increases to compensate for the increase in EA ensuring
that their ratio, EA/ELV, is matched for maximal efﬁciency at
rest. Indeed, signiﬁcant relationships exist between EA and ELV
ranging from correlations of 0.50 to 0.73 (Chen et al., 1998;
Borlaug et al., 2009) suggesting that a change in EA accounts
for a ≈25% change in ELV (Figure 4). This small percentage is
not surprising given that both components have multiple differ-
ent determinants. Nevertheless, older individuals with increased
arterial stiffness (EA) are more likely to have an increased left
ventricular stiffness (ELV), i.e., a stiffer heart coupled to a stiffer
vascular system. A consequence of the age-associated increase in
ELV, along with an increase in EA, essentially permits the EA/ELV
ratio to remain relatively matched (coupled; Cohen-Solal et al.,
1996; Chen et al., 1998, Redﬁeld et al., 2005). However, Redﬁeld
et al. (2005) did note a slight sex difference in EA/ELV with age
whereby healthy women demonstrated a slight decline in EA/ELV
with age, reﬂecting a disproportionate increase in ELV compared
with EA. This suggests a greater impact of aging on ventricular
vs. arterial properties in women compared to men, as indicated in
Figure 4.
Given that ELV is as a load-independent index of left ven-
tricular contractility (Sagawa, 1978), one might suggest that an
increase in ELV with age (andmore so inwomen) reﬂects enhanced
contractility. This is unlikely given that other measures of left
ventricular function do not increase with age (Lakatta, 1993).
Thus, what does the increase in ELV likely reﬂect? ELV is also
inﬂuenced by the structural/geometric and biochemical proper-
ties (i.e., stiffness or compliance of myocytes, composition of
muscle, ﬁbrosis, collagen, etc., in the heart wall) that underlie
left ventricular end-systolic stiffness (Borlaug and Kass, 2008;
Chantler et al., 2008a). Advancing age is also associated with
alterations in left ventricular structure. Most notably, there is a
reduction in myocyte number, and there is an increase in left
ventricular wall thickness and collagen deposition in the heart
(Olivetti et al., 1995; Lakatta, 2003). Thus, the increase in ELV
with age could represent differences in left ventricular geome-
try and/or structure between young and older individuals. For
example, concentric remodeling leads to a higher ELV (Borlaug
et al., 2009). However, the increase in ELV noted in Redﬁeld et al.
(2005) are unlikely to be due to differences in LV chamber size,
as similar results are obtained when ELV is normalized to end-
diastolic volume (a crude estimate of chamber size). An increase
in the amount (focal increases) and a change in the physical
properties of collagen (purportedly due to non-enzymatic cross-
linking) also occur within the myocardium with aging (Lakatta
and Levy, 2003). Thus, the increase in ELV with age is likely
attributed to a combination of left ventricular remodeling but
more so due to a loss of myocyte number and an increase
FIGURE 4 | Relationship between arterial (EAI) and left ventricular (ELVI)
elastance indexed to body surface area in healthy men (A) and women
(B) from the Baltimore longitudinal Study of Aging. Note the linear
relationship between EAI and ELVI irrespective of age and gender (Chantler
and Lakatta, unpublished data).
in myocardial collagen content, thereby increasing myocardial
stiffness.
DURING EXERCISE
During exercise EA has been shown to increase (Najjar et al.,
2004; Otsuki et al., 2006), decline (Asanoi et al., 1992), or remain
unchanged (Cohen-Solal et al., 1998). The response of EA dur-
ing exercise is dependent on the changes in its components and
has important consequences on the Frank–Starling mechanism
(Chantler et al., 2011). EA is linearly related to heart rate and
peripheral resistance, and inversely related to compliance (Segers
et al., 2002; Chemla et al., 2003, Otsuki et al., 2006; Chantler et al.,
2011). Both resistance and compliance usually decrease during
exercise (reﬂecting less resistance to blood ﬂow in the microcir-
culation, but increased stiffness of the conduit arteries) and the
relative contribution of the pulsatile component (compliance) to
EA increases, so that by 80% of peak exercise the resistive and the
pulsatile components provide nearly equal contributions to EA
(Otsuki et al., 2006). With advancing age, the ability to increase
heart rate, and lower resistance during exercise is blunted. In addi-
tion the reduction in compliance (due to a greater increase in pulse
Frontiers in Physiology | Vascular Physiology May 2012 | Volume 3 | Article 90 | 4
Chantler and Lakatta Aging and cardiovascular performance
pressure) is also limited during exercise (Lakatta, 1993; Fleg et al.,
1995). Although the blunted maximum cardiovascular responses
with age are, in part, due to older individuals achieving a lower
maximal workload, similar cardiovascular deﬁcits are also evi-
dent at submaximal workloads (Lakatta, 1993; Fleg et al., 1995).
The only study to directly examine the age-associated change in
EA/ELV in the absence of cardiovascular disease reported that EA,
in general, increases during exercise and that EA does not differ
between young and older subjects (Najjar et al., 2004). Perhaps
the blunted changes in resistance, compliance, and heart rate are
compensated for by the greater increase in blood pressure during
exercise in older vs. younger healthy individuals (Ogawa et al.,
1992). Indeed, some of the components of the changes in EA
seem to be related to each other (Chantler et al., 2012). That is,
greater preservation of compliance during exercise is associated
with a greater reduction in resistance (and a smaller increase in
mean and pulse pressure). This suggests that the tandem changes
in resistance and compliance appear to be linked, and raises the
possibility of a crosstalk between central and peripheral arter-
ies. Further, the change in EA during exercise is also linked to
a speciﬁc pattern of change in ventricular volumes and func-
tion. The change in EA is inversely related to the recruitment
of end-diastolic volume, and the enhancement of stroke volume
and cardiac output with exercise. Indeed individuals expressing
a large increase in EA during exercise demonstrate a blunted uti-
lization of the Frank–Starling mechanism, irrespective of age, sex,
and body size (Chantler et al., 2012). The cardiovascular system
responds to exercise by increasing cardiac output predominately
through an increase in heart rate, and in the upright position
stroke volume is increased. The perfusion of the tissues depends
both on the ability of the LV to produce ﬂow and sustain per-
fusion pressure. Thus, the speed and force of left ventricular
contraction increases during exercise and this is reﬂected by an
increase in ELV during exercise (Little and Cheng, 1993). Unlike
EA, aging impairs the increase in ELV during exercise. Najjar
et al. (2004) reports that the blunted increase in ELV with aging
begins to appear at 50% of maximal workload and that at max-
imal exercise older men and women (>60 years) have ≈40–55%
smaller ELV compared to men and women <40 years of age. A
consequence of the blunted increase in ELV during exercise in
older healthy individuals is a corresponding blunted reduction
in EA/ELV (Najjar et al., 2004). Furthermore, the altered cou-
pling noted at peak exercise with age is also associated with a
blunted increase in ejection fraction. Indeed, EA/ELV is inversely
related to ejection fraction [EA/ELV ≈ (1/ejection fraction)− 1;
Cohen-Solal et al., 1994]. The advantage of EA/ELV over ejec-
tion fraction is that examining the components of EA/ELV permits
evaluation of whether alterations in EA/ELV are due to alterations
in arterial properties, left ventricular properties, or both. Conse-
quently, advancing age is associated with a smaller EA/ELV (and
ejection fraction) reserve (EAI/ELVI peak− EA/ELV rest) and ELV
reserve (ELV peak− ELV rest; Najjar et al., 2004). Unlike at rest
when an increase in ELV could represent enhanced left ventric-
ular contraction, decreased left ventricular mass (or concentric
remodeling), or increased myocardial stiffness (due to alterations
in biochemical properties), an increase in ELV during exercise likely
reﬂects an increase in inotropy. This would suggest a decrease
in left ventricular contraction during exercise with increasing
age.
AGING–CV DISEASE INTERACTIONS AFFECT ARTERIAL
VENTRICULAR COUPLING
Unfortunately in today’s society, for the most part, aging is highly
linked to the occurrence of cardiovascular diseases. Further, car-
diovascular disease risk factors (obesity, hypercholesterolemia,
diabetes, and hypertension) often co-vary in number or sever-
ity with increasing age. Although measuring the age-associated
changes in cardiovascular structure and function in a “healthy”
aging population is important to provide insights into the normal
aging process, the generalizability of these ﬁndings are sometimes
limited. The age and disease interaction has important conse-
quences on arterial ventricular coupling both at rest and during
exercise as outlined below.
HYPERTENSION
The prevalence of hypertension markedly increases with advanc-
ing age, such that the relative risk of acquiring hypertension is
≈90% of individuals over 40 years of age (Lloyd-Jones et al.,
2009; Figure 5). Age-associated changes in arterial and left ven-
tricular structure and function are accelerated in the presence
of hypertension. Hypertensive patients exhibit greater carotid
wall thickness (Arnett et al., 1996), central arterial wall stiffness
(Amar et al., 2001), and reﬂected waves (Nichols et al., 1992)
than normotensive subjects, even after adjusting for age. Fur-
thermore, hypertension is associated with left ventricular remod-
eling and ﬁbrosis (Mayet and Hughes, 2003). As such, EA and
ELV are reported to be increased, between 15–60 and 16–95%,
respectively, in hypertensive patients compared with normoten-
sive controls (Cohen-Solal et al., 1994; Saba et al., 1999, Lam
et al., 2007). As with aging, however, the coupling ratio (EA/ELV)
remains matched (coupled) between normotensives and hyper-
tensives (Cohen-Solal et al., 1994; Saba et al., 1999). We found
similar results (matched EA/ELV due to tandem increase in EA and
ELV) when comparing men with predominantly systolic hyper-
tension to normotensive men. In contrast, women with predom-
inantly systolic hypertension, have a 23% lower resting EA/ELV
than normotensive women, a ﬁnding that persisted even after
adjusting for age (Chantler et al., 2008b). The lower EA/ELV in
women with systolic hypertension is due to a disproportion-
ate increase in ELV compared with EA (45 vs. 16%), suggesting
an adaptation by these women to limit the impact of systolic
hypertension on the vasculature or, alternatively, a more pro-
nounced impact of systolic hypertension on ventricular vs. arterial
elastance.
There are a limited number of studies that have examined the
coupling response during dynamic exercise in hypertensive indi-
viduals. Borlaug et al. (2010) showed that hypertensive individuals
express similar changes in EA, ELV and EA/ELV at submaximal and
maximal exercise compared to normotensive individuals matched
by age and sex. In contrast, Chantler et al. (2008b) reported that
the effects of predominantly systolic hypertension on the changes
in EA/ELV are similar between normotensive men and systolic
hypertensive men and women at 50% of maximal workload and
at peak upright bicycle exercise. In men, this is because EA and
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FIGURE 5 | Remaining lifetime risk for cardiovascular disease and other diseases among men and women free of disease at 40 years of age from the
Framingham Study. Modiﬁed from Lloyd-Jones et al. (2009).
ELV are proportionally higher at peak exercise in systolic hyper-
tensive compared with normotensive individuals. In women, this
is because EA and ELV are similar at peak exercise between sys-
tolic hypertensive and normotensivewomen. Thus,EA/ELV reserve
is similar between systolic hypertensive and normotensive men,
but 61% lower in systolic hypertensive vs. normotensive women
because of the uncoupling in EA/ELV at rest in these systolic
hypertensive women.
OBESITY
About one-third of U.S. adults (33.8%) are obese and the preva-
lence of overweight/obesity increases with advancing age.Obesity-
related conditions include heart disease, stroke, type 2 diabetes,
and certain types of cancer, some of the leading causes of death
(Flegal et al., 2010). The physiological changes that occur with
obesity are similar to those in hypertension, and often hyper-
tension and obesity co-exist in a given individual complicating
interpretations due to obesity alone (Stamler et al., 1978, 1991).
Indeed, Zebekakis et al. (2005) identiﬁed that obese individuals
(14% on antihypertensive medications) have increased carotid,
brachial, and femoral diameter with age, which remained sig-
niﬁcant after adjusting for differences in BP, medications, and
smoking status. Further, increasing body mass index is associated
with a reduced arterial distensibility (Zebekakis et al., 2005) and
increased arterial stiffness (Toto-Moukouo et al., 1986; Zebekakis
et al., 2005). In individuals with uncomplicated obesity (with-
out the presence of cardiovascular disease), an increase in body
mass index (45± 5 vs. 21± 2) is associated with an increase
in left ventricular mass (irrespective of normalized to height
or body surface area), and end-diastolic volume (unadjusted or
indexed to height; Rider et al., 2011). Although such alterations
in arterial and left ventricular structure/function increase rest-
ing EA and ELV in obese vs. non-obese controls, their coupling
(EA/ELV), however, remains matched, irrespective of body size.
Rider et al. (2011) noted a similar resting ejection fraction, which
is inversely related to EA/ELV, between individuals of various
body mass index categories. However, whether the increase in
EA and ELV noted in obese individuals represents the patho-
logic effects of excess adipose tissue on cardiovascular function,
or the normal physiological relationship between body size and
cardiovascular function is important to decipher. In order to
have meaningful clinical and scientiﬁc comparisons, differences
in body size must be accounted for (Chantler et al., 2005; Chantler
and Lakatta, 2009). Indeed, in the unadjusted form, resting EA
and ELV are slightly reduced (4 and 3%, respectively) in obese
vs. healthy non-obese controls (Chirinos et al., 2009). In con-
trast, when EA and ELV are scaled either ratiometrically or allo-
metrically to body surface area, EA and ELV are between 16–20
and 18–19% higher (p< 0.001) in obese vs. controls. Irrespec-
tive of the scaling technique employed there was no relationship
between obesity and EA/ELV (Chirinos et al., 2009). Unfortunately,
the changes in EA and ELV, and subsequently EA/ELV have not
been reported during dynamic exercise in obese vs. non-obese
individuals.
HEART FAILURE
Heart failure (HF) is a syndrome that is characterized by an inabil-
ity of the heart to pump a sufﬁcient amount of blood to meet
the demands of the metabolizing tissues, or can do so only at
the expense of elevated ﬁlling pressures (Adams et al., 2006). The
inability to meet the tissues’ demands is attributed to the ability,
or lack thereof, for the LV to ﬁll (diastolic properties) or to eject
(systolic properties) blood. Although there is considerable confu-
sion as to the pathological mechanisms that describes individuals
with systolic (HF with reduced ejection fraction), or diastolic
(HF with preserved ejection fraction) the coupling between the
heart and arteries does seem to be impacted differently by the
type of HF.
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HF WITH A REDUCED EF
Heart failure patients with systolic dysfunction are characterized
by a diminished resting ejection fraction and left ventricular con-
tractility (Asanoi et al., 1989). Patients with HF and a reduced
ejection faction have a downward and rightward shift of the end-
systolic pressure–volume relationship, reﬂecting a reduced ELV
(range 0.6–2.6mmHg·ml−1·m−2; Asanoi et al., 1989). Patients
with HF and a reduced ejection faction have an augmented EA
(range 1.7–3.7mmHg·ml−1·m−2) due to a decrease in stroke vol-
ume and increases in heart rate and peripheral resistance (Asanoi
et al., 1989). The increase in EA and decrease in ELV result in
a three to fourfold increase in EA/ELV (range 1.3–4.3; Asanoi
et al., 1989; Sasayama andAsanoi, 1991). This suboptimal coupling
reﬂects diminished cardiovascular performance and efﬁciency of
the failing heart.
During exercise, the traditional reduction in EA/ELV due to a
substantial increase in ELV vs. any change in EA are virtually absent
inHF patients with a reduced ejection fraction (Cohen-Solal et al.,
1998). Thus the limited capacity of systolicHFpatients to augment
their cardiovascular function during times of stress (such as exer-
cise) involve marked deﬁcits in both left ventricular and arterial
elastance reserves.
HF WITH A PRESERVED EF
Heart failure patients with a preserved ejection fraction (≥50%)
represent ≈40% of patients with HF (Owan et al., 2006). HF with
a preserved ejection fraction ismore prevalent with advancing age,
in women, and in individuals with systolic hypertension (Klapholz
et al., 2004). Recent interest has refocused attention on examining
the coupling between the heart (systolic and diastolic properties)
and arterial system in order to gain further insights into the patho-
physiological mechanisms that underlies HF with a preserved
ejection fraction. Some of the pathophysiological adaptations that
occur in HF with a preserved ejection fraction can be attributed
to normal adaptations evident with aging. Indeed the relative risk
(controlled for gender, race, medical history, and admission char-
acteristics) of developing HF with a preserved ejection fraction is
≈10–27% between 65 and 90 years of age (Masoudi et al., 2003).
However, aging alone does not account for all the physiologi-
cal changes noted in HF with a preserved ejection fraction. For
example, compared to age-matched normotensive controls, HF
patients with a preserved ejection fraction typically have an EA
that is ≈40% higher and an ELV that is approximately twofold
greater, and thus a lower EA/ELV is noted in HF patients with a
preserved ejection fraction vs. healthy controls (Kawaguchi et al.,
2003). However, when comparing HF patients with a preserved
ejection fraction with age, and hypertensive matched controls
without HF EA/ELV is similar because of a tandem rise in both
EA (≈40%) and ELV (≈50%) in HF patients with a preserved ejec-
tion fraction (Kawaguchi et al., 2003). In larger epidemiological
studies in whom EA/ELV is examined non-invasively, HF patients
with a preserved ejection fraction have matched increases in EA
and ELV (and thus similar EA/ELV) compared to non-hypertensive
controls without HF (Lam et al., 2007; Borlaug et al., 2009). Fur-
ther, no differences in EA and ELV, or EA/ELV are found between
individuals with hypertension without HF and HF patients with
a preserved ejection fraction (Lam et al., 2007; Borlaug et al.,
2009). Also the increase in ELV in HF patients with a preserved
ejection fraction compared to non-hypertensive controls is not
due to differences in left ventricular remodeling but more likely
due to an increased passive myocardial stiffening (Borlaug et al.,
2009). However, the vast majority of HF patients with a preserved
ejection fraction in these epidemiological studies are hyperten-
sive (>95%), which may contribute to the matched increases in
EA and ELV. Indeed, some patients with HF patients with a pre-
served ejection fraction who are normotensive have values of EA
and ELV that are similar to those of healthy normotensive con-
trols (Maurer et al., 2005). These ﬁndings highlight the difﬁculty
in understanding the pathophysiological mechanisms that are evi-
dent in a disease that is comprised of a very heterogeneous group
of individuals.
Recent studies have highlighted the importance of altered
arterial–ventricular interactions during exercise. HF patients with
a preserved ejection fraction who have increased EA and ELV at
rest exhibited a marked hypertensive response and elevated dias-
tolic pressures to sustained handgrip exercise (Kawaguchi et al.,
2003). Further, during upright cycle ergometry exercise at maxi-
mal effort, HF patients with a preserved ejection fraction have a
threefold smaller increase in ELV and a reduced ability to lower
their peripheral resistance and increase their heart rate during
exercise compared with hypertensive controls with left ventricular
hypertrophy (Borlaug et al., 2006). Some of the peak cardiovas-
cular deﬁcits noted between HF patients with a preserved ejec-
tion fraction and hypertensive controls could be related to the
fact that the HF patients with a preserved ejection fraction are
unable to attain the same level of exercise workload compared
to controls. In other words, are the peak cardiovascular deﬁcits a
mechanism or consequence of exercise limitation? However, sim-
ilar deﬁcits are also noted between HF patients with a preserved
ejection fraction and hypertensive controls at matched submax-
imal workloads (Borlaug et al., 2010). Thus, HF patients with
a preserved ejection fraction are characterized by a diminished
increase in ELV and a smaller reduction in EA/ELV compared to
controls without hypertension, and to those with hypertension
but without HF, both at submaximal exercise workloads (20W)
and at maximum exercise (Borlaug et al., 2010). In addition,
the depressed reserve responses correlated with reduced exercise
capacity and greater subjective symptoms at low-level workloads.
Since female sex, systolic hypertension, and older age are risk fac-
tors for HF with a preserved ejection fraction (Klapholz et al.,
2004), and as the pathophysiology of HF with a preserved ejec-
tion fraction involves a limited cardiovascular reserve (Kitzman
et al., 1991), the diminished EA/ELV reserve observed in older sys-
tolic hypertensive women without HF (Chantler et al., 2008b)
suggests that they may be exhibiting signs of subclinical (Stage
B) HF. This raises the possibility that they may be on a trajec-
tory to progressive exercise intolerance and perhaps functional
limitations.
In summary, the pathophysiological mechanisms that con-
tribute to HF with a preserved ejection fraction are due to
the accumulation of multiple cardiovascular impairments that
are expressed during exercise, reﬂecting impaired inotropic,
chronotropic, lusitropic, and vasodilatory responses that impair
EA/ELV (Kawaguchi et al., 2003; Borlaug et al., 2010).
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CONSEQUENCES OF ALTERATIONS IN EA/ELV WITH AGING,
HYPERTENSION, OR HEART FAILURE
In a young, healthy individual the coupling between the arteries
and heart are well matched to: (1) maintain an optimal trans-
fer of blood from heart to periphery without excessive changes
in blood pressure and; (2) provide optimal cardiovascular ﬂow
reserve without compromising arterial pressures (Kass, 2005).
However, the increased stiffness noted in both the arteries and
heart with age, which is further exacerbated in the presence of
disease (hypertension, HF, etc.) reﬂects a coupling disease (Kass,
2005). That is the stiff arteries and LV interact to limit the cardio-
vascular response to stress (reduced performance) and generates
clinical symptoms (Kass, 2005).
As illustrated inFigure 6, a stiffer heart-arterial system increases
load-sensitivity even if the coupling ratio is normal. That is, an
increased resting EA and ELV means that systolic pressures are
much more sensitive to changes in left ventricular volume. This is
clearly observed in young vs. old individuals, whereby a decreased
preload in younger individual results in a modest drop in sys-
tolic pressure but in older individuals there is a much greater
change in systolic pressure (Chen et al., 1998). This exaggerated
systolic pressure response is also evident in hypertensives and HF
patients with a preserved ejection fraction compared to controls
(Kawaguchi et al., 2003). Consequently, the stroke work (myocar-
dial demand) required to perform this task is increased and can
potently inﬂuence systolic and diastolic function, including coro-
nary ﬂow (i.e., greater dependence upon systolic pressure for
coronary ﬂow; Kawaguchi et al., 2003). Thus, older individuals
are working at a higher setpoint regarding changes in pressure for
a given change in loading conditions and this disadvantage is fur-
ther exaggerated in hypertensives andHFpatients with a preserved
ejection fraction.
In addition to enhanced load-sensitivity, the global (systolic
and diastolic) reserve capacity becomes blunted with arterial and
left ventricular stiffening. Increased ELV at rest translates into less
FIGURE 6 | Relationship between changes in systolic pressure to
alterations in ventricular diastolic volume (induced by balloon
obstruction of inferior vena caval inflow) in a young and in an elderly
patient.There is much greater sensitivity of systolic pressure to volume
changes in the elderly patient, indicated by the steeper slope. Modiﬁed
from Chen et al. (1998) with permission.
effective changes in ELV during exercise (or stress) thereby limiting
cardiovascular performance (Borlaug et al., 2010). For example,
individuals who start at a higher ELV have a limited capacity to
further increase stroke volume, and the limited stroke volume
response is further exacerbated when a stiff heart is connected
to a stiff artery (Chen et al., 1998; Kawaguchi et al., 2003). It is
therefore not surprising that a stiffer LV and arterial system are
linked to a reduced aerobic capacity (Borlaug et al., 2010). Fur-
ther, in an isolated canine heart model, Kass et al. (1989) reported,
larger reductions in ELV after a myocardial infarction in hearts
with a higher resting ELV. This greater mechanical vulnerability
to an ischemic insult may help to explain why older individuals
may experience worse outcomes following amyocardial infarction
(Maggioni et al., 1993).
Another a major consequence of arterial stiffening is an
increased pulse pressure, which also increases cyclic changes of
arterial ﬂow. As such, the microcirculation receives larger pul-
satile pressures which can damage the vascular beds and in turn,
cause damage to the end organs (such as the kidney and brain).
Indeed increased arterial stiffness is independently associated with
dementia (Hanon et al., 2005). Increased arterial stiffness can
also lead to endothelial dysfunction and an abnormal vasodilation
response to stress.
THERAPEUTIC INTERVENTIONS
Interventions related to improving arterial ventricular cou-
pling span from pharmacological to lifestyle (exercise and diet)
approaches. We will brieﬂy highlight some important interven-
tions in this area. The abnormalities in combined arterial and
ventricular stiffening leading to a mismatch in their interaction,
as highlighted above, has important physiological consequences.
Numerous approaches have been taken to reverse the age and dis-
ease associated changes. By reducing the increase in arterial and left
ventricular systolic stiffness with age or disease we may improve
arterial–ventricular interactions and thus cardiovascular perfor-
mancebybeingmore efﬁcient bloodpressure regulation for a given
volume of blood. For example, acute administration of sodium
nitroprusside, a balanced vasodilator, acutely reduces EA (10%)
and increases ELV (47%) at rest in older (70± 8 years) individuals
(Chantler et al., 2011). Further, at peak exercise, sodiumnitroprus-
side leads to an increase in ELV (68%) without a change in EA and
consequently the normal reduction in EA/ELV during exercise is
enhanced (36%). Importantly, sodiumnitroprusside acutely atten-
uates the age-associated deﬁcits in EA/ELV and ELV during exercise
(Chantler et al., 2011). Similarly, acute intravenous verapamil
(calcium-channel blocker) in healthy older (70± 10 years) volun-
teers reduces resting arterial–ventricular stiffening and EA during
exercise (though a decline in heart rate, pulsatile, and resistive
arterial load), and improves (13%) aerobic exercise performance
(Chen et al., 1999). These results in older persons highlight that, at
least acutely, the abnormalities in arterial–ventricular interactions
can be partly restored. Of note, verapamil also improved arterial
ventricular interactions and exercise capacity in HF patients with
a preserved ejection fraction and hypertrophic cardiomyopathy
(Brown et al., 1985; Setaro et al., 1990). However, whether the
acute effects of sodium nitroprusside or verapamil identiﬁed can
be maintained with chronic drug administration is unknown.
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Hypertensive patients on optimal brachial and central blood
pressure antihypertensive therapies shifts arterial–ventricular cou-
pling fromblood ﬂowmaximization to left ventricularmechanical
efﬁciency optimization (Osranek et al., 2008). Further, the effects
of antihypertensive monotherapy on EA/ELV examined in 10,670
patients over a 6-month period indicated that angiotensin con-
verting enzyme inhibitors (ACEI), angiotensin II receptor block-
ers (AIIRA), and dihydropyridine calcium antagonists decrease
EA/ELV, whereas diuretics, α-blockers, both β-blocker groups
(with and without intrinsic sympathomimetic activity), and non-
dihydropyridines signiﬁcantly increase EA/ELV compared to base-
line measurements (Figure 7; Iakovou et al., 2004). Thus various
antihypertensive drugs have a differential effect on EA/ELV with
ACEI, AIIRA, and dihydropyridine calcium antagonists have the
most favorable effect on this index, likely through their actions
on causing vasodilatation and by actually inhibiting the vasocon-
strictive results of neurohormonal activation (Iakovou et al., 2004).
However, the effects of these drugs on the components of EA/ELV
are not reported.
Other therapies shown to improve EA/ELV are exercise training.
In healthy older men, 24–32weeks of aerobic endurance exer-
cise training does not alter baseline ejection fraction (inverse
of EA/ELV) or left ventricular contractility (systolic blood
pressure/end-systolic volume), but increases peak ejection frac-
tion, suggesting that EA/ELV would have further decreased during
exercise, due to a greater peak left ventricular contractility (Schul-
man et al., 1996). In the same study, eight master athletes stopped
their endurance training for 12weeks, which tended to decrease
peak ejection fraction and LV contractility (Schulman et al., 1996).
In patients with coronary artery disease, 12months of aerobic
endurance exercise training did not alter resting EA/ELV,or ELV, but
produced a slight 13% reduction in EA at rest (Rinder et al., 1999).
Further, exercise training led to a 37% increase in ELV and a 23%
decrease in EA/ELV during handgrip exercise performed at 30% of
maximal voluntary contraction. However, the change in EA during
handgrip exercise remained unaltered after the exercise training.
The results of this study suggest that long-term endurance exercise
training induces signiﬁcant cardiovascular adaptations both in the
basal state and during an afterload stress in patients with coronary
artery disease.
One year of progressive and vigorous endurance training in
sedentary healthy older (70± 3 years) individuals resulted in slight
reductions in EA at rest (14%) and peak exercise (20%). This
coincided with an improvement in compliance at rest (Fujimoto
et al., 2010). However, the exercise training failed to reverse car-
diac stiffening. One possible reason for the lack of changes in
left ventricular stiffness with exercise training is the development
of cross-linked advanced glycation end products in the left ven-
tricular wall along with a loss in the number and the volume
of cardiac myocytes that occur with older age and which are
pathologically irreversible once formed (Aronson, 2003). Thus any
improvement in left ventricular function could have been con-
strained by cross-linked collagen. A phase II drug, alagebrium,
is a cross-link breaker and is known to improve left ventricular
and arterial stiffness in animals (Kass, 2003), and a clinical trial is
currently underway to examine the effects of exercise and alage-
brium combined on cardiovascular stiffening in the elderly (NIH
clinicaltrials.gov identiﬁer NCT01014572). However, alagebrium
administered to patients with HF and systolic dysfunction does
not improve exercise tolerance or cardiac function (Hartog et al.,
2011). Whether HF patients with a preserved ejection fraction, in
whom the largest effect of alagebrium could be expected, would
beneﬁt from an advanced glycation end products breaker therapy
remains unknown.
FIGURE 7 | Arterial–ventricular coupling (AVC) percentage changes
after antihypertensive monotherapy in 10,670 patients over
6months of treatment. Abbreviations: ACE inhibitors, angiotensin
converting enzyme inhibitors; AIIRA, angiotensin II receptor antagonists;
ISA, intrinsic sympathomimetic activity. From Iakovou et al. (2004) with
permission.
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CONCLUSION
Although increased stiffness of the arteries itself has important
physiological and clinical relevance, such changes also have major
implications on the heart, and vice versa, and the manner in the
way they interact has important ramiﬁcations on cardiovascu-
lar function both at rest and during exercise. Examination of the
alterations in arterial–ventricular coupling with aging and disease
can yield mechanistic insights into the pathophysiology of these
conditions and increase the effectiveness of current therapeutic
interventions. Future studies should identify agents to chroni-
cally reverse increases in EA and ELV that occur with age and
disease. Furthermore, longitudinal studies are needed to evaluate
whether alterations in EA/ELV, EA, and ELV provide any prognostic
information for adverse outcomes, such as HF.
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